Impact of HIV status on outcome of infectious complications in intravenous drug users. by Mertz, D, Viktorin, N, Wolbers, M, Flückiger, U, Battegay, M

Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma. by Gasser, O, Wolbers, M, Steffen, I, Hirsch, H, Battegay, M, Hess, C

General and specific immunosuppression caused by antiviral T-cell responses. by Zinkernagel, R, Planz, O, Ehl, S, Battegay, M, Odermatt, B, Klenerman, P, Hengartner, H

Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis by Mertz, D, Viktorin, N, Wolbers, M, Laifer, G, Leimenstoll, B, Fluckiger, U, Battegay, M

Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. by Battegay, M, Bachmann, M, Burhkart, C, Viville, S, Benoist, C, Mathis, D, Hengartner, H, Zinkernagel, R

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy. by Gasser, O, Brander, C, Wolbers, M, Brown, N, Rauch, A, Günthard, H, Battegay, M, Hess, C

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. by Wolbers, M, Bucher, H, Furrer, H, Rickenbach, M, Cavassini, M, Weber, R, Schmid, P, Bernasconi, E, Hirschel, B, Battegay, M

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. by Wolbers, M, Battegay, M, Hirschel, B, Furrer, H, Cavassini, M, Hasse, B, Vernazza, P, Bernasconi, E, Kaufmann, G, Bucher, H

Fibroblasts as efficient antigen-presenting cells in lymphoid organs. by Kündig, T, Bachmann, M, DiPaolo, C, Simard, J, Battegay, M, Lother, H, Gessner, A, Kühlcke, K, Ohashi, P, Hengartner, H

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. by Gasser, O, Bihl, F, Wolbers, M, Loggi, E, Steffen, I, Hirsch, H, Günthard, H, Walker, B, Brander, C, Battegay, M, Hess, C

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy by Gasser, O, Brander, C, Wolbers, M, Brown, N, Rauch, A, Günthard, H, Battegay, M, Hess, C, Battegay, M, Bernasconi, E, Böni, J, Bucher, H, Bürgisser, P, Calmy, A, Cattacin, S, Cavassini, M, Dubs, R, Egger, M, Elzi, L, Fischer, M, Flepp, M, Fontana, A, Francioli, P, Furrer, H, Fux, C

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. by Glass, T, Ungsedhapand, C, Wolbers, M, Weber, R, Vernazza, P, Rickenbach, M, Furrer, H, Bernasconi, E, Cavassini, M, Hirschel, B, Battegay, M, Bucher, H

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. by Hasse, B, Walker, A, Fehr, J, Furrer, H, Hoffmann, M, Battegay, M, Calmy, A, Fellay, J, Di Benedetto, C, Weber, R, Ledergerber, B

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. by Khanna, N, Wolbers, M, Mueller, N, Garzoni, C, Du Pasquier, R, Fux, C, Vernazza, P, Bernasconi, E, Viscidi, R, Battegay, M, Hirsch, H

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. by Wolbers, M, Opravil, M, von Wyl, V, Hirschel, B, Furrer, H, Cavassini, M, Vernazza, P, Bernasconi, E, Battegay, M, Yerly, S, Günthard, H, Bucher, H

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. by Rohrbach, J, Robinson, N, Harcourt, G, Hammond, E, Gaudieri, S, Gorgievski, M, Telenti, A, Keiser, O, Günthard, H, Hirschel, B, Hoffmann, M, Bernasconi, E, Battegay, M, Furrer, H, Klenerman, P, Rauch, A

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. by di Iulio, J, Ciuffi, A, Fitzmaurice, K, Kelleher, D, Rotger, M, Fellay, J, Martinez, R, Pulit, S, Furrer, H, Günthard, H, Battegay, M, Bernasconi, E, Schmid, P, Hirschel, B, Barnes, E, Klenerman, P, Telenti, A, Rauch, A

Response to combination antiretroviral therapy: variation by age. by Sabin, C, Smith, C, d'Arminio Monforte, A, Battegay, M, Gabiano, C, Galli, L, Geelen, S, Gibb, D, Guiguet, M, Judd, A, Leport, C, Dabis, F, Pantazis, N, Porter, K, Raffi, F, Thorne, C, Torti, C, Walker, S, Warszawski, J, Wintergerst, U, Chene, G, Lundgren, J

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. by Fagard, C, Oxenius, A, Günthard, H, Garcia, F, Le Braz, M, Mestre, G, Battegay, M, Furrer, H, Vernazza, P, Bernasconi, E, Telenti, A, Weber, R, Leduc, D, Yerly, S, Price, D, Dawson, S, Klimkait, T, Perneger, T, McLean, A, Clotet, B, Gatell, J, Perrin, L, Plana, M, Phillips, R, Hirschel, B

Human immunodeficiency virus-specific T lymphocyte cell by Oxenius, A, Mclean, A, Fischer, M, Price, D, Dawson, S, Hafner, R, Schneider, C, Joller, H, Hirschel, B, Phillips, R, Weber, R, Günthard, H, Battegay, M, Bucher, H, Bernasconi, E, Piffaretti, J, Bürgisser, P, Francioli, P, Pantaleo, G, Rickenbach, M, Telenti, A, Egger, M, Erb, P, Klimkait, T, Fierz, W